{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:54:52Z","timestamp":1793130892085,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SB\/YS\/LS-106\/2014"],"award-info":[{"award-number":["SB\/YS\/LS-106\/2014"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.biopha.2018.02.052","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T07:10:52Z","timestamp":1521702652000},"page":"379-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer\u2019s disease via activation of Nrf2\/ARE pathway and inhibition of \u03b2-secretase"],"prefix":"10.1016","volume":"101","author":[{"given":"Kartik T.","family":"Nakhate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish P.","family":"Bharne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Sagar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali N.","family":"Aru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dadasaheb M.","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.02.052_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-2009-0960","article-title":"Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer\u2019s disease","volume":"16","author":"Huang","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-014-0089-7","article-title":"BACE1 inhibitor drugs in clinical trials for Alzheimer\u2019s disease","volume":"6","author":"Vassar","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2018.02.052_bib0015","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","article-title":"Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation","volume":"31","author":"Shipton","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.50","article-title":"Astrocytes are important mediators of A\u03b2-induced neurotoxicity and tau phosphorylation in primary culture","volume":"2","author":"Garwood","year":"2011","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","article-title":"Inflammatory processes in Alzheimer\u2019s disease","volume":"27","author":"McGeer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2018.02.052_bib0030","first-page":"208","article-title":"Drugs for Alzheimer\u2019s disease: are they effective?","volume":"35","author":"Casey","year":"2010","journal-title":"P.T."},{"key":"10.1016\/j.biopha.2018.02.052_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/153331750602100211","article-title":"Herbal medicine in the treatment of Alzheimer\u2019s disease","volume":"21","author":"Akhondzadeh","year":"2006","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.biopha.2018.02.052_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0973-7847.99898","article-title":"Neuroprotective potential of phytochemicals","volume":"6","author":"Kumar","year":"2012","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.biopha.2018.02.052_bib0045","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1074\/jbc.M601595200","volume":"281","author":"Sandur","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.02.052_bib0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/jpet.110.170852","article-title":"Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-\u03baB activation","volume":"335","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.02.052_bib0055","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1471-4159.2010.06780.x","article-title":"Plumbagin promotes the generation of astrocytes from rat spinal cord neural progenitors via activation of the transcription factor Stat3","volume":"115","author":"Luo","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2018.02.052_bib0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1471-4159.2009.06552.x","article-title":"Plumbagin, a novel Nrf2\/ARE activator, protects against cerebral ischemia","volume":"112","author":"Son","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2018.02.052_bib0065","first-page":"495","article-title":"Plumbagin protects against spinal cord injury-induced oxidative stress and inflammation in Wistar Rats through Nrf-2 upregulation","volume":"65","author":"Zhang","year":"2015","journal-title":"Drug Res. (Stuttg.)"},{"key":"10.1016\/j.biopha.2018.02.052_bib0070","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.pharep.2015.03.001","article-title":"Antidepressant-like activity of plumbagin in unstressed and stressed mice","volume":"67","author":"Dhingra","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"2015","key":"10.1016\/j.biopha.2018.02.052_bib0075","article-title":"Enhanced neuroprotective effects of coadministration of tetrandrine with glutathione in preclinical model of Parkinson\u2019s disease","author":"Li","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0080","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3233\/JAD-2010-090667","article-title":"Neuroinflammation in Alzheimer\u2019s disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?","volume":"21","author":"Trepanier","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.intimp.2009.03.022","article-title":"Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes","volume":"9","author":"Checker","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/alzrt150","article-title":"NF-\u03baB-regulated, proinflammatory miRNAs in Alzheimer\u2019s disease","volume":"4","author":"Lukiw","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2018.02.052_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.physbeh.2012.06.019","article-title":"Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin","volume":"107","author":"Santos","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2018.02.052_bib0100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/ijms17091447","article-title":"Toxin-induced experimental models of learning and memory impairment","volume":"17","author":"More","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0105","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1038\/onc.2012.493","article-title":"Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity","volume":"32","author":"Arlt","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.02.052_bib0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","article-title":"A non-transgenic mouse model (icv-STZ mouse) of Alzheimer\u2019s disease: similarities to and differences from the transgenic model (3xTg-AD mouse)","volume":"47","author":"Chen","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0115","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1038\/s41598-017-02961-0","article-title":"Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer\u2019s disease: emphasis on inhibition of \u03b2-amyloid, COX-2, alpha-, beta-secretases and APH1a","volume":"7","author":"Halawany","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.02.052_bib0120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.lfs.2009.10.007","article-title":"Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated by neuropeptide Y Y1 and Y5 receptors","volume":"85","author":"Bhisikar","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0125","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neuroscience.2014.07.062","article-title":"Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice","volume":"277","author":"Desai","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.02.052_bib0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vascn.2011.08.002","article-title":"A simple and inexpensive method to fabricate a cannula system for intracranial injections in rats and mice","volume":"64","author":"Kokare","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.biopha.2018.02.052_bib0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2013.12.014","article-title":"Involvement of the central melanocortin system in the effects of caffeine on anxiety-like behavior in mice","volume":"95","author":"Bhorkar","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0140","series-title":"The Mouse Brain in Stereotaxic Co-Ordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.biopha.2018.02.052_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2015.11.040","article-title":"Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice","volume":"1631","author":"Liu","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exger.2017.03.007","article-title":"Treatment effects of Cardiotrophin-1 (CT-1) on streptozotocin-induced memory deficits in mice","volume":"92","author":"Wang","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.07.055","article-title":"Involvement of cocaine- and amphetamine-regulated transcript peptide in the hyperphagic and body weight promoting effects of allopregnanolone in rats","volume":"1532","author":"Nakhate","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.lfs.2010.12.008","article-title":"Cocaine- and amphetamine-regulated transcript peptide increases spatial learning and memory in rats","volume":"88","author":"Upadhya","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.peptides.2012.01.004","article-title":"Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer\u2019s disease","volume":"33","author":"Rangani","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2018.02.052_bib0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/ijmm.2014.1801","article-title":"Bushen\u2011Yizhi formula ameliorates cognition deficits and attenuates oxidative stress\u2011related neuronal apoptosis in scopolamine\u2011induced senescence in mice","volume":"34","author":"Hou","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.02.052_bib0175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pbb.2010.09.001","article-title":"Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis, Pharmacol","volume":"97","author":"Nakhate","year":"2010","journal-title":"Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.02.052_bib0180","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ijo.2010.231","article-title":"Central regulation of feeding behavior during social isolation of rat: evidence for the role of endogenous CART system","volume":"35","author":"Nakhate","year":"2011","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2018.02.052_bib0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuropharm.2012.10.028","article-title":"Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice","volume":"67","author":"Bharne","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2018.02.052_bib0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2009.03.008","article-title":"Involvement of neuropeptide Y Y (1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats","volume":"609","author":"Nakhate","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2016.05.035","article-title":"Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes","volume":"1646","author":"Nakhate","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.physbeh.2011.09.001","article-title":"Involvement of CART in estradiol induced anorexia","volume":"105","author":"Dandekar","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2018.02.052_bib0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","article-title":"Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor","volume":"290","author":"Hong","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.02.052_bib0210","article-title":"Molecular docking using ArgusLab, an efficient shape-based search algorithm and the AScore scoring function","volume":"172","author":"Thompson","year":"2004"},{"key":"10.1016\/j.biopha.2018.02.052_bib0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","article-title":"Developing beta-secretase inhibitors for treatment of Alzheimer\u2019s disease","volume":"120","author":"Ghosh","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2018.02.052_bib0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.biopha.2018.02.052_bib0225","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/med.20235","article-title":"Perspectives on medicinal properties of plumbagin and its analogs","volume":"32","author":"Padhye","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2018.02.052_bib0230","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4103\/1673-5374.160076","article-title":"Streptozotocin induced Alzheimer\u2019s disease like changes and the underlying neural degeneration and regeneration mechanism","volume":"10","author":"Kamat","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000350435","article-title":"Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol","volume":"98","author":"Jing","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.biopha.2018.02.052_bib0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1567202612666150311111340","article-title":"Etanercept improves cognitive performance and increases eNOS and BDNF expression during experimental vascular dementia in streptozotocin-induced diabetes","volume":"12","author":"Utkan","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0245","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer\u2019s disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"2013","key":"10.1016\/j.biopha.2018.02.052_bib0255","first-page":"1","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2018.02.052_bib0260","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-013-8539-y","article-title":"Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice","volume":"49","author":"Chen","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JAD-2009-1202","article-title":"Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer\u2019s disease and other neurodegenerative conditions","volume":"18","author":"Koudinov","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2478\/s13380-014-0225-7","article-title":"Neuroinflammation and Alzheimer\u2019s disease: lessons learned from 5-lipoxygenase","volume":"5","author":"Joshi","year":"2014","journal-title":"Trans. Neurosci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2012-120958","article-title":"Streptozotocin-induced sporadic Alzheimer\u2019s disease: selection of appropriate dose","volume":"33","author":"Mehla","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12116","article-title":"Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3beta pathway in streptozotocin-induced Alzheimer rat model","volume":"24","author":"Gao","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/pri.22512","article-title":"Astrocyte signaling and neurodegeneration: new insights into CNS disorders","volume":"7","author":"Brambilla","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.biopha.2018.02.052_bib0290","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0295","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0306-4522(02)00230-0","article-title":"Chronic gliosis triggers Alzheimer\u2019s disease-like processing of amyloid precursor protein","volume":"113","author":"Bates","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.02.052_bib0300","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12035-013-8559-7","article-title":"Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats","volume":"49","author":"Moghaddam","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0305","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/1673-5374.153695","article-title":"Neurons in the hippocampal CA1 region, but not the dentate gyrus, are susceptible to oxidative stress in rats with streptozotocin-induced type 1 diabetes","volume":"10","author":"Lee","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2018.02.052_bib0310","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pbb.2009.09.022","article-title":"Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats","volume":"94","author":"Saxena","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.02.052_bib0315","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE study","volume":"60","author":"Green","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(02)01338-9","article-title":"Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model","volume":"440","author":"Knapp","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2018.02.052_bib0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2015.12.003","article-title":"Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer\u2019s Disease","volume":"291","author":"Sil","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0335","first-page":"31","article-title":"Experimental brain inflammation and neurodegeneration as model of Alzheimer\u2019s disease: protective effects of selective COX-2 inhibitors","volume":"16","author":"Giovannini","year":"2003","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0340","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/jn\/135.10.2299","article-title":"Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats","volume":"135","author":"Dias","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2018.02.052_bib0345","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/bbrc.2000.2959","article-title":"COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice","volume":"273","author":"Tabatabaie","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.02.052_bib0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2007.01.060","article-title":"Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice","volume":"416","author":"Shin","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.02.052_bib0355","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1073858405278321","article-title":"Reactive astrocytes in neural repair and protection","volume":"11","author":"Sofroniew","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.biopha.2018.02.052_bib0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.12-208660","article-title":"Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice","volume":"27","author":"Kraft","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2018.02.052_bib0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2010.05.036","article-title":"Bimodal effect of interferon-\u03b2 on astrocyte proliferation and survival: importance of nuclear factor-\u03baB","volume":"226","author":"Barca","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0370","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/ars.2008.2242","article-title":"The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease","volume":"11","author":"Calkins","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2018.02.052_bib0375","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/db11-0807","article-title":"Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy","volume":"60","author":"Zheng","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.02.052_bib0380","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.redox.2013.08.006","article-title":"Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells","volume":"1","author":"Steele","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx."},{"key":"10.1016\/j.biopha.2018.02.052_bib0390","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","article-title":"A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations","volume":"107","author":"Carpenter","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2018.02.052_bib0395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2005.10.018","article-title":"Increased cholesterol in A\u03b2-positive nerve terminals from Alzheimer\u2019s disease cortex","volume":"28","author":"Gylys","year":"2007","journal-title":"Neurobio. Aging"},{"key":"10.1016\/j.biopha.2018.02.052_bib0400","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: a possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hern\u00e1ndez","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0405","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2018.02.052_bib0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-7091-6467-9_15","article-title":"Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles","volume":"53","author":"Iqbal","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.biopha.2018.02.052_bib0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2017.11.012","article-title":"Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats","volume":"113","author":"Mishra","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2018.02.052_bib0420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: A mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2018.02.052_bib0425","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-017-0241-2","article-title":"Role of neuroinflammation in neurodegeneration: new insights","volume":"9","author":"McManus","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"2011","key":"10.1016\/j.biopha.2018.02.052_bib0430","first-page":"12","article-title":"Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration","author":"Numakawa","year":"2011","journal-title":"J. Toxicol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0435","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740836","article-title":"A potential role for apoptosis in neurodegeneration and Alzheimer\u2019s disease","volume":"10","author":"Cotman","year":"1995","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.02.052_bib0440","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.nbd.2011.12.016","article-title":"Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice","volume":"45","author":"Aoyama","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2018.02.052_bib0445","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-\u03baB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.02.052_bib0450","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/ncomms4496","article-title":"Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52","volume":"5","author":"Jo","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217361401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217361401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:35:18Z","timestamp":1760096118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217361401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":90,"alternative-id":["S0753332217361401"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.052","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer\u2019s disease via activation of Nrf2\/ARE pathway and inhibition of \u03b2-secretase","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}